Journal
Frontiers in Nuclear Medicine
Publication Date
1-1-2023
Volume
3
First Page
1193880
Document Type
Open Access Publication
DOI
10.3389/fnume.2023.1193880
Rights and Permissions
Hlongwa K, Kolade O, Alnabulsi A, Steyn R, Brink A, Prasad V and More S (2023) Case report: Peptide receptor radioligand therapy in metastatic pediatric neuroendocrine tumors. Front. Nucl. Med. 3:1193880. doi: 10.3389/fnume.2023.1193880 © 2023 Hlongwa, Kolade, Alnabulsi, Steyn, Brink, Prasad and More. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Hlongwa, Khanyisile; Kolade, Olumayowa; Alnabulsi, Abdulilah; Steyn, Rachelle; Brink, Anita; Prasad, Vikas; and More, Stuart, "Case report: Peptide receptor radioligand therapy in metastatic pediatric neuroendocrine tumors." Frontiers in Nuclear Medicine. 3, 1193880 (2023).
https://digitalcommons.wustl.edu/oa_4/5638
